Literature DB >> 22186240

State of the art treatment of nasal polyposis.

Rony K Aouad1, Alexander G Chiu.   

Abstract

BACKGROUND: Nasal polyposis represents the end point of multiple inflammatory pathways and controversy continues as to the exact roles of medical and surgical approaches in the management of nasal polyposis.
METHODS: A combination of both is often required to manage polyps adequately with surgery and intranasal steroids remaining the mainstay of therapy.
RESULTS: Fortunately, new technological advances are making surgery safer and more efficient. In the postoperative period, debridement is effective in reducing the formation of adhesions, and topical medications may play a beneficial role in preventing polyp reformation.
CONCLUSION: Additional investigations into the optimal perioperative medical management is needed to ensure optimal surgical outcomes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22186240     DOI: 10.2500/ajra.2011.25.3681

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN: 1945-8932            Impact factor:   2.467


  7 in total

Review 1.  The use of postoperative topical corticosteroids in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis.

Authors:  Marcela Fandiño; Kristian I Macdonald; John Lee; Ian J Witterick
Journal:  Am J Rhinol Allergy       Date:  2013 Sep-Oct       Impact factor: 2.467

Review 2.  Targeting key proximal drivers of type 2 inflammation in disease.

Authors:  Namita A Gandhi; Brandy L Bennett; Neil M H Graham; Gianluca Pirozzi; Neil Stahl; George D Yancopoulos
Journal:  Nat Rev Drug Discov       Date:  2015-10-16       Impact factor: 84.694

3.  Does oral prednisolone increase the efficacy of subsequent nasal steroids in treating nasal polyposis?

Authors:  Virat Kirtsreesakul; Krongthong Wongsritrang; Suwalee Ruttanaphol
Journal:  Am J Rhinol Allergy       Date:  2012 Nov-Dec       Impact factor: 2.467

4.  The effect of corticosteroid therapy on cyclooxygenase 2, vascular endothelial growth factor, and inducible nitric oxide synthase expression levels in nasal polyposis.

Authors:  Demet Yazici; Ülkü Tuncer; Aysun Uğuz
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06       Impact factor: 2.503

5.  Availability of preoperative systemic steroids on endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis.

Authors:  Seok Jin Hong; Jong Kyu Lee; Hyun Sub Lee; Jung Yup Lee; Jung Soo Pyo; Kyung Chul Lee
Journal:  Yonsei Med J       Date:  2014-11       Impact factor: 2.759

6.  Effects of intranasal steroid treatment on the presence of biofilms in non-allergic patients with chronic rhinosinusitis with nasal polyposis.

Authors:  Péter Csomor; István Sziklai; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-08-25       Impact factor: 2.503

7.  Effects of cryotherapy on the maxillary antrostomy patency in a rabbit model of chronic rhinosinusitis.

Authors:  Anamaria Gocea; Marian Taulescu; Veronica Trombitas; Silviu Albu
Journal:  Biomed Res Int       Date:  2013-10-28       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.